The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 18,901–19,000 of 31,469
Chan, D. C., Watts, G. F., Ooi, E. M. M., Chan, D. T., Wong, A. T. Y., & Barrett, P. H. R. (2011) · Metabolism · doi:10.1016/j.metabol.2011.03.003 · Cited by 13
Karschin, J., Lagerpusch, M., Enderle, J., Eggeling, B., Müller, M. J., & Bosy‐Westphal, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117865 · Cited by 13
Ikeda, N., Nakajima, R., Tsunoda, T., Nakamura, M., & Sugi, K. (2007) · Heart and Vessels · doi:10.1007/s00380-006-0956-7 · Cited by 14
Fouda, N., Abd-Elaziz, H., & Foda, E. M. (2014) · The Egyptian Rheumatologist · doi:10.1016/j.ejr.2013.12.001 · Cited by 13
Beijers, H. J. B. H., Henry, R. M. A., Bravenboer, B., Ferreira, I., Dekker, J. M., Nijpels, G., & Stehouwer, C. D. A. (2011) · American Journal of Hypertension · doi:10.1038/ajh.2010.256 · Cited by 13
Reduced venous endothelial responsiveness after oral lipid overload in healthy volunteers
Signori, L. U., da Silva, A. M. V., Plentz, R. D. M., Geloneze, B., Moreno, H., Belló‐Klein, A., Irigoyen, M. C., & Schaan, B. D. (2007) · Metabolism · doi:10.1016/j.metabol.2007.08.012 · Cited by 13
Malavazos, A. E., Cereda, E., Ermetici, F., Caccialanza, R., Briganti, S., Rondanelli, M., & Morricone, L. F. (2015) · International Journal of Endocrinology · doi:10.1155/2015/836941 · Cited by 13
Prehipertensión arterial en adultos jóvenes
Galeano, I. O., Morales, P. F., Notario‐Pacheco, B., et al. (2012) · Revista Clínica Española · doi:10.1016/j.rce.2012.03.008 · Cited by 13
Sun, D., Liu, S., Zhang, G., Chen, W., Yan, Z., & Hu, S. (2012) · Obesity Surgery · doi:10.1007/s11695-012-0744-7 · Cited by 13
Kosmidou, M., Hatzitolios, A., Adamidou, A., Giannopoulos, S., Raikos, N., Parharidis, G., & Milionis, H. (2008) · American Journal of Hypertension · doi:10.1038/ajh.2007.61 · Cited by 15
Atenolol Exposure and Risk for Development of Adverse Metabolic Effects: A Pilot Study
Navare, H., Frye, R. F., Cooper‐DeHoff, R. M., Shuster, J. J., Hall, K., Schmidt, S. O., Turner, S. T., & Johnson, J. A. (2010) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.30.9.872 · Cited by 13
Sun, D., Liu, S., Zhang, G., et al. (2013) · Surgical Endoscopy · doi:10.1007/s00464-013-3272-1 · Cited by 13
Effect of insulin sensitivity on SHBG levels in premenopausal versus postmenopausal obese women
Akın, F., Baştemir, M., & Alkış, E. (2007) · Advances in Therapy · doi:10.1007/bf02877767 · Cited by 13
Arciello, M., Petta, S., Leoni, V., et al. (2011) · Digestive and Liver Disease · doi:10.1016/j.dld.2011.10.022 · Cited by 13
Koerner, M. M., El‐Banayosy, A., Eleuteri, K., et al. (2014) · The Heart Surgery Forum · doi:10.1532/hsf98.2013323 · Cited by 13
Okuno, A., Kaji, N., TAKAHASHI, A., et al. (2013) · Journal of Veterinary Medical Science · doi:10.1292/jvms.13-0230 · Cited by 13
Anuurad, E., Shiwaku, K., Enkhmaa, B., Nogi, A., Kitajima, K., Yamasaki, M., & Yamane, Y. (2004) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2004.01413.x · Cited by 13
Satoh, H., Kudoh, A., Hasegawa, K., Hirai, H., & Watanabe, T. (2013) · Diabetology International · doi:10.1007/s13340-013-0150-y · Cited by 13
Alonso‐Villaverde, C., Aragonès, G., Beltrán‐Debón, R., et al. (2010) · Cytokine · doi:10.1016/j.cyto.2010.05.008 · Cited by 13
Khoudary, S. R. E., Wildman, R. P., Matthews, K. A., Powell, L. H., Hollenberg, S. M., Edmundowicz, D., & Sutton-Tyrrell, K. (2011) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3182099dd2 · Cited by 13
Fatty liver and chronic inflammation in Chinese adults
Wang, P., Hsieh, C., Psang, L.-C., Cheng, Y., Liou, C., Weng, S., Chen, J., Chen, I., Li, R.-H., & Eng, H. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.04.014 · Cited by 13
Ohgushi, M., Taniguchi, A., Fukushima, M., Nakai, Y., Kuroe, A., Ohya, M., Nagasaka, S., Taki, Y., Yoshii, S., Matsumoto, K., et al. (2007) · Metabolism · doi:10.1016/j.metabol.2006.12.007 · Cited by 13
Jackson, K. G., Delgado‐Lista, J., Gill, R. D., Lovegrove, J. A., Williams, C. M., López‐Miranda, J., & Minihane, A. M. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.08.035 · Cited by 13
Sobngwi, E., Kengne, A. P., Echouffo-Tcheugui, J. B., Choukem, S. P., Sobngwi-Tambekou, J. L., Balti, E. V., Pearce, M. S., Siaha, V., Mamdjokam, A. S., Effoe, V. S., et al. (2014) · BMC Endocrine Disorders · doi:10.1186/1472-6823-14-65 · Cited by 13
Greig, F., Hyman, S. J., Wallach, E., Hildebrandt, T., & Rapaport, R. (2011) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2011.00792.x · Cited by 12
Tenor, D. P., Berenguer, J., García–Álvarez, M., et al. (2014) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000491 · Cited by 13
Sagae, S. C., Lubaczeuski, C., Zacharias, P., Bonfleur, M. L., Franci, C. R., & Sanvitto, G. L. (2013) · Physiology & Behavior · doi:10.1016/j.physbeh.2013.05.029 · Cited by 13
Tenor, D. P., Berenguer, J., García‐Broncano, P., Jiménez‐Sousa, M. Á., Fernández‐Rodríguez, A., Díez, C., García–Álvarez, M., Carrero, A., Catalán, P., Aldámiz‐Echevarría, T., et al. (2014) · European Journal of Clinical Investigation · doi:10.1111/eci.12250 · Cited by 13
Román, C. L., Flores, L. E., Maiztegui, B., et al. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.09.011 · Cited by 13
Ghio, A., Seghieri, G., Lencioni, C., et al. (2012) · International Journal of Endocrinology · doi:10.1155/2012/460509 · Cited by 13
Insulin Resistance and Serum Levels of Interleukin-17 and Interleukin-18 in Normal Pregnancy
Jahromi, A. S., Shojaei, M., & Ghobadifar, M. A. (2014) · Immune Network · doi:10.4110/in.2014.14.3.149 · Cited by 13
Fukuda, H., Imamura, M., Tanaka, Y., Iwata, M., Hirose, H., Kaku, K., Maegawa, H., Watada, H., Tobe, K., Kashiwagi, A., et al. (2013) · Journal of Human Genetics · doi:10.1038/jhg.2013.28 · Cited by 13
Mong, J. L. Y., Ng, M. C. Y., Guldan, G. S., Tam, C. H. T., Lee, E. H. M., Ma, R. C. W., So, W., Wong, G., Kong, A. P. S., Chan, J. C. N., et al. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.186 · Cited by 13
Hou, X., Wang, C., Wang, S., Yang, W., Ma, Z., Wang, Y., Li, C., Li, M., Zhang, X., Zhao, X., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111173 · Cited by 13
Wallner, L. P., Hollingsworth, J. M., Dunn, R. L., et al. (2013) · Urology · doi:10.1016/j.urology.2013.05.034 · Cited by 13
C‐reactive protein and incidence of type 2 diabetes in the Pizarra study
Rubio‐Martín, E., Soriguer, F., Gutiérrez‐Repiso, C., Garrido‐Sánchez, L., de Adana, M. R., García‐Fuentes, E., Morcillo, S., Esteva, I., Chaves, F. J., & Rojo‐Martínez, G. (2012) · European Journal of Clinical Investigation · doi:10.1111/eci.12027 · Cited by 14
Aerobic Exercise Training Attenuates Obesity-Related Hypogonadism in Male Rats
You, T., DiSanzo, B., & Arsenis, N. C. (2013) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e318285816c · Cited by 13
Rehme, M. F. B., Pontes, A. G., Corrente, J. E., Franco, J. G., Jr., & Pontes, A. (2013) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1590/s0100-72032013001200006 · Cited by 13
Song, B., Rhee, Y., Kim, C. O., Youm, Y., Kim, K. T., Lee, E. M., Lee, J. M., Yoon, Y. W., & Kim, H. C. (2014) · Nutrients · doi:10.3390/nu6125806 · Cited by 13
da Rocha, N. P., Siqueira-Catania, A., de Barros, C. R., Monfort‐Pires, M., Folchetti, L. D., & Ferreira, S. R. G. (2010) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302010000700008 · Cited by 14
Adipokines and endothelial dysfunction in obesity WHO°III
Bachmayer, C., Kemmer, A., Ehrmann, N., Hasenberg, T., Lammert, A., & Hammes, H. (2013) · Microvascular Research · doi:10.1016/j.mvr.2013.04.007 · Cited by 13
A biological, latent variable model of health (EarlyBird 68)
Hyland, M. E., Jeffery, A., & Wilkin, T. J. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.02.018 · Cited by 15
Ku, Y. H., Choi, S. H., Lim, S. K., Cho, Y. M., Park, Y. J., Park, K. S., Kim, S. Y., & Jang, H. C. (2011) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2011.35.5.497 · Cited by 13
Ballestero, Y., López‐Herce, J., González, R., et al. (2014) · BMC Endocrine Disorders · doi:10.1186/1472-6823-14-25 · Cited by 13
Benbaibeche, H., Haffaf, E. M., Kacimi, G., et al. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114515000549 · Cited by 13
Lindblad, Y. T., Axelsson, J., Barany, P. F., et al. (2008) · Blood Purification · doi:10.1159/000167799 · Cited by 13
Tungsiripat, M., El‐Bejjani, D., Rizk, N., Dogra, V. S., O’Riordan, M. A., Ross, A. C., Hileman, C. O., Storer, N. J., Harrill, D., & McComsey, G. A. (2010) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2010.0187 · Cited by 13
Derosa, G., Maffioli, P., Ferrari, I., Palumbo, I., Randazzo, S., D’Angelo, A., & Cicero, A. F. G. (2010) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3388p · Cited by 13
Cui, A.-D., Gai, N.-N., Zhang, X., Jia, K.-Z., Yang, Y., & Song, Z. (2012) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-4-52 · Cited by 13
Lwow, F., Dunajska, K., Milewicz, A., Łaczmański, Ł., Jędrzejuk, D., Trzmiel-Bira, A., & Szmigiero, L. (2012) · Climacteric · doi:10.3109/13697137.2012.738721 · Cited by 13
Increased microalbuminuria prevalence among patients with nonalcoholic fatty liver disease
Kasapoğlu, B., Türkay, C., Yalçın, K. S., et al. (2015) · Renal Failure · doi:10.3109/0886022x.2015.1106845 · Cited by 13
Kinoshita, T., Doi, K., Sugiyama, H., Kinoshita, S., Wada, M., Naruto, S., & Tomonaga, A. (2011) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2011.01151.x · Cited by 14
Association of monocyte CCR2 expression with obesity and insulin resistance in postmenopausal women
Jakšić, V. P., Gizdić, B., Miletić, Z., Trutin-Ostović, K., & Jakšić, O. (2013) · Clinical and investigative medicine · doi:10.25011/cim.v36i1.19402 · Cited by 13
The Prediabetes Detection and Physical Activity Intervention Delivery (PRE-PAID) Program
Rowan, C. P., Riddell, M. C., & Jamnik, V. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.09.003 · Cited by 14
Domingo, P., Lamarca, K., Gallego-Escuredo, J. M., Torres, F., Domingo, J. C., Villarroya, J., Gutierrez, M. D. M., Mateo, G. M., Vidal, F., Villarroya, F., et al. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv027 · Cited by 13
Brand, C. L., Galsgaard, E. D., Tornehave, D., Rømer, J., Gotfredsen, C. F., Wassermann, K., Knudsen, L. B., Vølund, A., & Sturis, J. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01049.x · Cited by 13
Taguchi, T., Mori, H., Hamada, A., et al. (2012) · PubMed · Cited by 13
Hegedűs, C., Kovács, D. K., Kiss, R., et al. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115602952 · Cited by 13
Rubin, D., Helwig, U., Nothnagel, M., Fölsch, U. R., Schreiber, S., & Schrezenmeir, J. (2010) · European Journal of Endocrinology · doi:10.1530/eje-09-0446 · Cited by 13
Jowitt, L. M., Lu, L. W., & Rush, E. C. (2014) · PubMed · doi:10.6133/apjcn.2014.23.3.06 · Cited by 13
Gupta, S. K., Slaven, J. E., Kamendulis, L. M., et al. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv195 · Cited by 13
Næraa, R. W., Gravholt, C. H., Kastrup, K. W., Svenstrup, B., & Christiansen, J. (2001) · Acta Paediatrica · doi:10.1111/j.1651-2227.2001.tb00793.x · Cited by 13
Truitt, K. E., Goldberg, R. B., Rosenstock, J., Chou, H. S., Merante, D., Triscari, J. M., & Wang, A. C. (2010) · Current Medical Research and Opinion · doi:10.1185/03007991003715079 · Cited by 13
Lundström, A., Wallén, H., von Arbin, M., Jörneskog, G., Gigante, B., Dembrower, K., Laurenčikas, E., & Laska, A. C. (2015) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2015.06.024 · Cited by 12
Clinical Factors Associated with Carotid Plaque and Intima-Medial Thickness in HIV-Infected Patients
Jeong, S. J., Kim, H. W., Ku, N. S., Han, S. H., Kim, C. O., Choi, J. Y., Song, Y. G., & Kim, J. M. (2013) · Yonsei Medical Journal · doi:10.3349/ymj.2013.54.4.990 · Cited by 13
Exercise improves cardiac function and attenuates insulin resistance in Dahl salt-sensitive rats
Stevens, A. L. M., Ferferieva, V., Bito, V., Wens, I., Verboven, K., Deluyker, D., Voet, A., Vanhoof, J., Dendale, P., & Eijnde, B. O. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.03.094 · Cited by 13
Gilglioni, E. H., Campos-Shimada, L. B., de Oliveira, M. C., Garcia, R. F., Ambiel, C. R., Buzzo, A. J. D. R., Ishii‐Iwamoto, E. L., & Salgueiro‐Pagadigorria, C. L. (2012) · The Journals of Gerontology Series A · doi:10.1093/gerona/gls210 · Cited by 13
Epicardial Fat Tissue Thickness in Preeclamptic and Normal Pregnancies
Can, M. M., Can, E., Özveren, O., Okuyan, E., Ayça, B., & Dinçkal, M. H. (2012) · ISRN Obstetrics and Gynecology · doi:10.5402/2012/389539 · Cited by 13
Sossa, C. J., Delisle, H. F., Aguèh, V., Makoutodé, M., & Fayomi, B. (2012) · European Journal of Preventive Cardiology · doi:10.1177/2047487312460214 · Cited by 13
Ma, H., Lin, H., Hu, Y., Li, X., He, W., Jin, X., Gao, J., Zhao, N., Liu, Z., & Gao, X. (2014) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-14-197 · Cited by 13
Torun, E., Aydın, S. G., Gökçe, S., et al. (2014) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2014.5552 · Cited by 13
Rosen, J. B., Ballantyne, C. M., Hsueh, W. A., Lin, J., Shah, A. K., Lowe, R. S., & Tershakovec, A. M. (2015) · Lipids in Health and Disease · doi:10.1186/s12944-015-0075-5 · Cited by 13
Cheng, S.-H., Ismail, A., Anthony, J., et al. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/405615 · Cited by 13
Dimitroulas, T., Sandoo, A., Hodson, J. A., Smith, J., Douglas, K., & Kitas, G. D. (2015) · Scandinavian Journal of Rheumatology · doi:10.3109/03009742.2015.1086433 · Cited by 14
Ibarretxe, D., Girona, J., Amigó, N., et al. (2015) · Journal of clinical lipidology · doi:10.1016/j.jacl.2015.12.012 · Cited by 13
Boyer, W. R., Johnson, T. M., Fitzhugh, E. C., Richardson, M. R., & Churilla, J. R. (2016) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2015.0077 · Cited by 13
Yongsakulchai, P., Settasatian, C., Settasatian, N., Komanasin, N., Kukongviriyapan, U., Coté, M. L., Intharapetch, P., & Senthong, V. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.03.005 · Cited by 13
Omotosho, P. A., Mor, A., Shantavasinkul, P. C., Corsino, L., & Torquati, A. (2016) · Surgical Endoscopy · doi:10.1007/s00464-015-4568-0 · Cited by 13
Gazolla, F. M., Bordallo, M. A. N., Madeira, I. R., et al. (2015) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2014-0116 · Cited by 13
Gentile, M., Iannuzzi, A., Iannuzzo, G., Covetti, G., Panico, S., Mattiello, A., Michele, M. D., & Rubba, P. (2012) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31825ad66c · Cited by 13
Rosettenstein, K., Viecelli, A. K., Yong, K., et al. (2015) · Transplantation · doi:10.1097/tp.0000000000000949 · Cited by 13
Akıncı, A., Karakurt, C., Gürbüz, S., Elkran, O., Nalbantoğlu, Ö., Koçak, G., Güldür, T., & Yoloğlu, S. (2012) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e328351674e · Cited by 13
Ovariectomized High Fit Rats Are Protected against Diet-Induced Insulin Resistance
Park, Y.-M., Kanaley, J., Zidon, T., Welly, R., Scroggins, R. J., Britton, S., Koch, L., Thyfault, J., Booth, F., Padilla, J., et al. (2016) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000000898 · Cited by 10
Chia, P.-P., Fan, S.-H., & Say, Y. (2015) · Ethnicity & Disease · doi:10.18865/ed.25.4.383 · Cited by 13
Ersoy, A. Ö., Tokmak, A., Özler, S., Öztaş, E., Ersoy, E., Çelik, H. T., Erdamar, H., & Yılmaz, N. (2016) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-016-4096-8 · Cited by 13
松嶋, 由., Takeshita, Y., Kita, Y., Otoda, T., Kato, K., Wakakuri, H., Akahori, H., Shimizu, A., Hamaguchi, E., Nishimura, Y., et al. (2016) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2015-000190 · Cited by 13
FACTORS RELATED TO NON‐ALCOHOLIC FATTY LIVER DISEASE IN OBESE CHILDREN
Dalgıç, B., Çamurdan, M., Eminoglu, F., et al. (2006) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/j.1536-4801.2006.tb01741.x · Cited by 13
Corona-Meraz, F.-I., Navarro-Hernández, R. E., Ruíz-Quezada, S. L., Madrigal-Ruíz, P.-M., Castro-Albarrán, J., Chavarría-Ávila, E., Guzmán-Ornelas, M.-O., Gómez-Bañuelos, E., Petri, M. H., Ramírez-Cedano, J.-I., et al. (2016) · Mediators of Inflammation · doi:10.1155/2016/3085390 · Cited by 13
Li, L., Yin, X., Yu, D., & Li, H. (2016) · Internal Medicine · doi:10.2169/internalmedicine.55.4943 · Cited by 15
Gabr, S. A., Alghadir, A. H., Allam, A. A., Ajarem, J. S., Al-Basher, G., Abdel-Maksoud, M. A., Ghfar, A. A., & Aboud, A. (2016) · Clinical Interventions in Aging · doi:10.2147/cia.s104599 · Cited by 13
Vangoitsenhoven, R., Frederiks, P., Gijbels, B., Lannoo, M., der Borght, W. V., den Eynde, A. V., Mertens, A. C., Mathieu, C., & der Schueren, B. V. (2016) · Acta Clinica Belgica · doi:10.1080/17843286.2016.1174393 · Cited by 15
Guo, C., Sun, T.-T., Weng, X.-D., et al. (2015) · PubMed · Cited by 13
González‐Jiménez, E., Schmidt‐RioValle, J., Alonso, M. Á. M., Padez, C. M. P., García, C. J. G., & Perona, J. S. (2016) · Biological Research For Nursing · doi:10.1177/1099800416648207 · Cited by 15
Positive correlation between serum IGF-1 and HDL-C in type 2 diabetes mellitus
Song, X., Teng, J., Wang, A., Li, X., Wang, J., & Liu, Y. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.04.056 · Cited by 14
CRY1 and CRY2 genetic variants in seasonality: A longitudinal and cross-sectional study
Kovanen, L., Donner, K. M., Kaunisto, M. A., & Partonen, T. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.05.044 · Cited by 14
Progranulin is increased in human and murine lipodystrophy
Miehle, K., Ebert, T., Kralisch, S., Hoffmann, A., Kratzsch, J., Schlögl, H., Stümvoll, M., & Faßhauer, M. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.07.017 · Cited by 12
de Luis, D. A., Izaola, O., de la Fuente, B., Primo, D., & Aller, R. (2016) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.12406 · Cited by 13
Liu, D., Qu, H., Wang, H., Duan, Y., Liu, F., Feng, Z., & Deng, H. (2016) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2016.08.004 · Cited by 13
Hirowatari, Y., Manita, D., Kamachi, K., & Tanaka, A. (2016) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563216672247 · Cited by 13
de Luis, D. A., Izaola, O., de la Fuente, B., Primo, D., & Aller, R. (2016) · Lifestyle Genomics · doi:10.1159/000452131 · Cited by 13
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
